Seonglae ChoNovo Nordisk's CagriSema combines semaglutide, the active ingredient in Ozempic and Wegovy, with an amylin and calcitonin receptor agonist.
A new stronger Ozempic is coming. Here's what to know
Novo Nordisk revealed more about CagriSema, its potential successor to the weight loss drug Ozempic
https://qz.com/novo-nordisk-cagrisema-ozempic-1851691005
